Skip to Main Content

Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation, especially since it appears there may be a benefit in doing so. Our choice today is maple bourbon. Meanwhile, here is the latest menu of tidbits to help you on your way. Have a wonderful day, and please do stay in touch. …

Amid criticism over its approach to Covid-19, the pharmaceutical industry issued a new “declaration” to work closer with intra-governmental groups in order to provide greater access to medicines and vaccines in future pandemics, STAT says. Toward that end, the industry listed three priorities: enhance and streamline product development; speed manufacturing to generate high volumes of products; and allocate supplies to priority populations. But governments should widen clinical trial networks, boost regulatory approval strategies, fund pandemic preparedness and procurement mechanisms for low-income countries, not issue trade restrictions, and maintain intellectual property rights.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment